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Nutrition in CAPD: Serum bicarbonate and the ubiquitin-pro- Protein metabolism in patients with uncomplicated
teasome system in muscle. chronic renal failure (CRF) responds in the same fashion
Background. Metabolic acidosis in chronic renal failure as that of normal adults leading to the conclusion that(CRF) induces loss of lean body mass while elimination of
some complication of CRF causes protein malnutritionacidosis during a one year trial improved anthropometric indi-
in renal failure patients [1, 2]. However, signs of malnu-ces in continuous ambulatory peritoneal dialysis (CAPD) pa-
tients. In rats with CRF, the mechanisms causing loss of lean trition are common in patients treated by hemodialysis
body mass have been linked to acidosis-induced destruction or continuous ambulatory peritoneal dialysis (CAPD)
of the essential, branched-chain amino acids (BCAA) and acti- [3–6] and one sign, a low serum albumin, is the strongestvation of the ubiquitin-proteasome system that degrades mus-
independent risk factor for death in hemodialysis pa-cle protein; the latter response includes increased transcription
tients [7]. Interpreting changes in serum albumin, how-of the ubiquitin gene.
Method. Our aim was to determine if increasing the serum ever, is complicated because inflammation as well as an
bicarbonate (HCO3) concentration of CAPD patients would inadequate diet can decrease serum albumin [8, 9].
improve their nutritional status, increase plasma BCAA levels,
Acidosis is a common complication of CRF and canand reduce ubiquitin mRNA in their muscle as an index of
cause patients to lose lean body mass by preventing thesuppressed activity of the ubiquitin-proteasome system. Eight,
stable, long-term CAPD patients underwent vastus lateralis activation of adaptive responses that maintain protein
muscle biopsy before being randomized to continue 35 mmol/L stores [10, 11]. The clinical connections among renal
lactate dialysate or convert to a 40 mmol/L lactate dialysate. failure, metabolic acidosis and nutritional abnormali-
After four weeks, measurements were repeated.
ties were suggested as early as 1931 by Lyon, DunlopResults. Serum HCO3 increased in all patients and final val-
and Stewart [12], and more recently it was shown thatues did not differ statistically between the two groups so results
for all patients were combined. Weight and body mass index acidosis suppresses the growth of otherwise normal in-
increased significantly as did plasma BCAA. Muscle levels of fants and children and causes negative nitrogen balance
ubiquitin mRNA decreased significantly; serum tumor necrosis and increased protein and branched-chain amino acidsfactor- (TNF-) also decreased.
(BCAA) oxidation in adults with CRF, including thoseConclusion. Our results indicate that even a small correction
treated by hemodialysis or CAPD [11, 13–18]. Theseof serum HCO3 improves nutritional status, and provide evi-
dence for down-regulation of BCAA degradation and muscle adverse outcomes can be overcome by providing supple-
proteolysis via the ubiquitin-proteasome system. Whether aci- mental alkali. Perhaps the most impressive example of
dosis and inflammatory cytokines (such as, TNF-) interact to this strategy is the study of Stein, Walls and colleaguesimpair nutrition is unknown.
[19]. They randomly assigned 200 CAPD patients with
metabolic acidosis to treatment with a dialysate solution
of 35 mmol/L lactate or to a dialysate of 40 mmol/L
lactate. After one year, both groups of patients had a
higher serum HCO3, had gained weight and had an in-
†Deceased. crease in mid-arm muscle circumference compatible with
an increase in muscle mass. The patients treated with 40Key words: acidosis, protein degradation, chronic renal failure, branched-
chain amino acids, diet and dialysis. mmol/L lactate dialysate had greater increases in these
values than did the patients treated with 35 mmol/LReceived for publication July 31, 2001
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nutritional status. Firstly, NH4Cl-feeding stunts the growth sol four times between 0800 and 1600 hours, and we
collected the dialysate effluent and 24-hour urine sam-of normal rats and increases their excretion of urea nitro-
gen and 3-methylhistidine (a marker of muscle protein ples of the first five patients and measured cortisol. This
was done because of the interactions among glucocorti-breakdown) [20]. Secondly, acidosis stimulates the break-
down of protein and branched-chain amino acids (BCAA) coids, metabolic acidosis and muscle metabolism [21, 29,
30]. Cortisol values in the dialysate and urine were belowin intact rats and in isolated muscles [21–23]. Thirdly, aci-
dosis activates specific pathways in muscle to degrade the detection level of the assay (25 nmol/24 h) and
serum cortisol measurements were within the rangeprotein and BCAA, namely, the ubiquitin-proteasome
system and branched-chain ketoacid dehydrogenase or found in the blood of normal adults sampled at the same
time of day. Since no pattern of changes in serum cortisolBCKAD [24–26]. These catabolic responses in muscle
include increased levels of mRNAs encoding compo- values emerged, these measurements were discontinued.
After their initial evaluations, the patients were ran-nents of the ubiquitin-proteasome system and BCKAD
[24, 27]. domized to continue with the 35 mmol/L dialysate or
were changed to a 40 mmol/L lactate dialysate plus oralTo determine if the mechanisms identified in acidotic
CRF rats also are active in humans, we used the proto- supplements of NaHCO3 (up to 600 mg thrice daily)
and/or CaCO3 (up to 500 mg twice daily). The dosescol of Stein, Walls and coworkers to assess whether
raising the serum HCO3 would improve indices of nutri- were adjusted in an attempt to maintain the serum HCO3
above 25 mmol/L as described [19]. Serum chemistrytional status, BCAA concentrations in plasma, and re-
duce ubiquitin mRNA in muscle. Our results indicate values were monitored weekly; after four weeks a second
muscle biopsy, anthropometric measurements and otherthat even a small improvement in serum HCO3 can regu-
late catabolic pathways to improve protein nutrition in blood values were obtained.
Serum chemistry values were measured with an Ekta-CAPD patients.
chem multiple analyzer and arterial blood gases with a
Corning 238 blood gas analyzer. Insulin was measured
METHODS
by radioimmunoassay, TNF- by enzyme-linked immu-
Continuous ambulatory peritoneal dialysis patients nosorbent assay (ELISA; Quantikine DTA50; R&D Sys-
were enrolled in a prospective examination of the rela- tems, Minneapolis, MN, USA), pre-albumin by immuno-
tionship between an increase in serum HCO3 and nutri- precipitation (IncStar Corporation, Stillwater, MN, USA)
tional status. Informed written consent in accordance and 3-methylhistidine by high pressure liquid chroma-
with the procedures of the Leicester General Hospital tography (HPLC) [11]. Plasma concentrations of the
ethics committee was obtained from eight CAPD/CCPD branched-chain amino-acids were measured by HPLC
patients (7 men, 1 woman with a mean age 61.9 6 years). [31] and ubiquitin mRNA in muscle biopsies was mea-
The duration of peritoneal dialysis before the start of sured by Northern blotting [24, 29]. Briefly, RNA was
the study averaged 29.8  3 months (minimum, 10 isolated from the muscle samples using TriReagent (Mo-
months). The patients were well nourished with an aver- lecular Research Centre, Cincinnati, OH, USA) and sep-
age body mass index (BMI) of 25.5  1.2 kg/m2, while arated in a formaldehyde/agarose gel by electrophoresis
the serum albumin averaged 36.6  1.1 g/L. No patient before transfer to a ZetaProbe GT membrane (Bio-Rad,
had diabetes mellitus, malignancy, vasculitis, a recent Richmond, CA, USA). The blots were stained with
episode of peritonitis, or was eating a vegetarian diet. methylene blue to visualize the 18S and 28S ribosomal
During an initial three-month period, the patients re- RNA bands, and then hybridized with a cDNA probe
ceived dialysis with a standard dialysate of 35 mmol/L for chicken ubiquitin (this cDNA is highly homologous
lactate. Alkali supplements (calcium carbonate and/or to mammalian ubiquitin mRNAs, and thus, it hybridizes
sodium bicarbonate) were withheld and patients were with human ubiquitin mRNA) that was labeled with
observed to ensure there was no complicating illness. 32P-dCTP by the random primer method. After overnight
Throughout the study, the prescribed dialysis volumes hybridization at 65C, the membranes were washed once
and frequencies were kept constant. At week 0 (w0), with 2  standard sodium citrate (SSC)/0.5% sodium
anthropometric indices were measured and a three-day dodecyl sulfate (SDS) at 42C followed by two washes
food diary was evaluated by a clinical dietician. A blood with 0.5  SSC/0.5% SDS at 65C. The washed mem-
sample was obtained to measure serum chemistries and branes were then exposed to x-ray film at 80C with
transferrin, pre-albumin, insulin, and tumor necrosis intensifier screens. Autoradiographic bands were quanti-
factor- (TNF-) values plus plasma BCAA levels. In fied using the SigmaGel software package (Jandel Soft-
addition, arterial blood was withdrawn for blood gas and ware, San Rafael, CA, USA). To account for differences
pH analysis and after local anesthesia, a muscle biopsy in lane loading, the intensity of each ubiquitin autoradio-
from the vastus lateralis muscle was obtained using the graphic band was divided by the intensity of the methyl-
ene blue-stained 18S ribosomal RNA band (18S andconchotome method [28]. We also measured serum corti-
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Table 2. Laboratory values of CAPD patients beforeTable 1. Serum bicarbonate and plasma pH values of
CAPD patients and after treatment
W0 value W4 Change P valueW0 HCO3 W4 W0 W4
mmol/L Change pH Change
Creatinine lmol/L 98163 1840 NS
Serum urea mmol/L 17.22.3 0.11.0 NS35 mmol/L Lactate 22.01.1 2.20.6 7.410.02 0
P0.02 Body weight kg 74.23.3 0.60.2 0.015
Body mass index kg/m2 25.51.2 0.20.1 0.03540 mmol/L Lactate 242.5 5.70.7 7.360.03 0.090
P0.014 Midarm circumference cm 28.91.0 0.10.2 NS
Tricep skinfold thickness mm 12.11.2 0.71.0 NSCombined 22.81.1 3.50.7 7.390.02 0.030.02
P0.002 Dietary protein 64.84.2 0.73.9 NS
Caloric intake 1951115 10174 NSData are mean  SE. W0 and W4 are weeks zero and four, respectively.
Serum albumin g/L 36.61.1 1.50.8 NS
Serum prealbumin g/L 380.532.4 28.532.8 NS
TNF- pg/L 15.40.5 1.40.4 0.008
Serum transferrin g/L 1.810.10 0.030.07 NS
Serum insulin mU/L 29.47.0 1.65.3 NS28S ribosomal RNA levels were not different between
treatment groups). Abbreviations are: NS, not significant; W, week; TNF-, tumor necrosis factor-.
Results are presented as mean SEM. Statistical anal-
yses included analysis of variance (ANOVA) in compar-
ing values between the groups and the paired t test when
four weeks was slightly, but not statistically lower at thecomparing changes in values occurring in the individual
time of the second biopsy (Table 2). The amount ofpatients. Differences were considered significant when
dietary protein was unchanged (Table 2).P  0.05.
Factors related to nutritional status
RESULTS The average serum albumin and prealbumin concen-
Acid/base status trations did not change significantly (Table 2). Likewise,
serum transferrin and insulin did not change significantlyDuring the four weeks of study, each patient had an
(Table 2). In contrast, the serum level of TNF- de-improvement in their serum HCO3 concentration: those
creased significantly (Table 2).treated with the 35 mmol/L lactate dialysate improved
by 2.2  0.6 mmol/L (P  0.02; Table 1) and those
Evidence that the increase in serum HCO3treated with 40 mmol/L lactate by 5.7  0.7, (P 
down-regulates catabolic pathways0.014; Table 1). The final serum HCO3 concentration in
The increase in serum HCO3 was associated with evi-the two groups did not differ significantly. Six of the
dence for regulation of the catabolic pathways that de-eight patients had a serum HCO3 of 	25 mmol/L irre-
grade protein and BCAA. In muscle, ubiquitin mRNAspective of their dialysate lactate concentration and the
(corrected for loading using the respective 18S rRNAother two patients had an increase in serum HCO3 of 1
level) decreased significantly over the four weeks (W0and 4 mmol/L. Our hypothesis was that an increase in
1.49  0.07 arbitrary units, W4 change  0.26  0.08serum HCO3 would improve indices of nutritional status
units; P  0.016; Fig. 1). Secondly, the plasma BCAAand decrease the ubiquitin mRNA level in muscle. Be-
levels increased with correction of acidosis (Table 3). Thecause all patients had an increase in serum HCO3 to
increase in valine and isoleucine values were statisticallysimilar final values, we combined results from all subjects
higher (P  0.04) while the increase in leucine ap-in subsequent analyses. Notably, the patients treated for
proached a statistically significant value (P  0.07).one month by Stein and colleagues with 35 mmol/L lac-
tate dialysis also had an average serum HCO3 of 26
mmol/L (although at the end of the one year study, it
DISCUSSIONwas 23 mmol/L) [19].
Acidosis is associated with negative nitrogen balanceThe arterial blood pH also increased slightly (Table 1)
and degradation of BCAA and protein in patients withbut the change was not statistically significant. There
kidney disease [11, 15–18]. In animals, the mechanismswere no significant changes in serum creatinine or urea
accounting for these defects involve stimulation of theconcentrations (Table 2).
activities of BCKAD and the ubiquitin-proteasome pro-
Nutritional status teolytic system [22–24, 27]. Presumably, the same mecha-
nisms are active in patients. Our results support thisAfter four weeks, there was a statistically significant
conclusion and point out that these metabolic abnormali-increase in body weight and body mass index (BMI;
ties can be improved even in patients who have only aTable 2). There was no change in midarm circumference
slightly low serum HCO3 simply by ensuring an increasenor in triceps skinfold thickness (Table 2). After an anal-
ysis of dietary diaries, we found that energy intake after in serum HCO3.
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Table 3. Serum branched-chain amino acids concentrations
Week 0 Week 4 change
Amino acid lmol/L P value
Leucine 83.35.8 17.98.3 0.07
Isoleucine 69.65.1 11.34.5 0.04
Valine 1558.0 23.49.4 0.04
quitin mRNA in muscle. However, the longer-term study
of Stein et al in which a higher serum HCO3 was associ-
ated with greater weight gain and muscle mass suggests
that it is the correction of acidosis rather than changes
in dialysis that accounted for the improvements in nutri-
tional status [19]. The study included only one woman,
but her values uniformly responded in the same direction
as those of the men.
We also wished to determine if any influence of a
higher serum HCO3 would differ with the two dialysates.
Unfortunately, we could not examine this question for
several reasons: the two dialysates did not yield statisti-
cally different values of serum HCO3 or arterial blood
pH after one month; and there was no correlation be-
tween the different outcomes and the serum HCO3 in
individual patients. However, the number of patients in
each group was small and when the results were sub-
jected to ANOVA, there was no significant difference
between the two groups in terms of changes ubiquitin
mRNA, BMI or changes in nutritional status. Regard-
less, we cannot exclude the possibility of an interaction
between the type of dialysate and the level of serumFig. 1. (A). Representative Northern blots of muscle RNA isolated
from 2 of 8 patients and hybridized with a ubiquitin cDNA. The 2.4 kb HCO3. Because of the invasive nature of the procedures
and 1.2 kb ubiquitin mRNAs were detected. The corresponding 18S used and the positive results obtained in patients in both
and 28S ribosomal bands are shown below the respective Northern blot
groups, we did not attempt to obtain greater differencesautoradiograph. (B). Ubiquitin mRNA in muscle before and after the
4-week study was measured by Northern blot and normalized using the in serum HCO3 in larger numbers of patients.
18S ribosomal RNA. Ubiquitin mRNA results are expressed in arbitrary May et al reported that plasma and muscle BCAA
units. Symbols are: () week 0 and () week 4 values for each patient.
levels were lower in non-uremic acidotic rats comparedOverall, the differences were statistically significant with P  0.016.
to pair-fed control rats, and that this response was related
to increased activity of BCKAD [26]. We did not mea-
sure BCKAD activity in muscle of these CAPD patients
Our hypothesis for this study was that an increase in because of the small muscle sample, but did find that
serum HCO3 (as a surrogate for an improved acid-base plasma BCAA levels were higher when the serum HCO3
status) would be the “signal” to suppress catabolic path- levels increased. This finding is consistent with suppres-
ways. We found that the serum HCO3 increased in both sion of BCKAD activity in muscle, the major site for
groups as reported previously using the same protocol BCAA degradation in vivo [33].
[19]. A potential explanation for the increase in serum The inference from the decrease in ubiquitin mRNA
HCO3 in patients continuing treatment with the 35 in muscle is that it reflects a decrease in proteolytic activ-
mmol/L lactate dialysate is better compliance with the ity of the ubiquitin-proteasome system [25]. While pro-
prescribed dialysis regimen. Indeed, Bernardini, Nagy tein degradation in muscle was not measured, two types
and Piraino reported that as many of 30% of CAPD of evidence support this inference. (1) Garibotto et al
patients completed less than 90% of prescribed changes, assessed arteriovenous flux of amino acids in the forearm
although this fraction decreased in patients on longer- muscle of acidotic, CRF patients and found higher rates
term dialysis [32]. We cannot exclude the possibility that of protein degradation in those with lower serum HCO3
a change in the dialysis schedule was responsible for the values [30]. The patients’ weights did increase during the
four weeks of our study and a similar protocol pursuedhigher plasma levels of BCAA and lower levels of ubi-
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for a year found an increase in both body weight and What other signals might change the activity of the
muscle mass; however, there was no measurable increase ubiquitin-proteasome in CAPD patients? In a model of
in muscle mass in our study [19]. (2) Every study of diabetes, we found that there is excessive muscle protein
experimentally-induced catabolic conditions character- degradation due to activation of the ubiquitin-protea-
ized by muscle protein degradation via the ubiquitin- some system with an accompanying increase in the ubi-
proteasome system revealed a corresponding increase in quitin mRNA level [41, 42]. Since both uremia and meta-
ubiquitin mRNA in muscle. In the model of metabolic bolic acidosis are associated with insulin resistance, it is
acidosis in CRF, this increase was prevented simply by possible that the increase in serum HCO3 improved the
feeding NaHCO3 to the acidotic CRF rat [24, 25]. action of insulin [43, 44]. However, we found no consis-
Other investigators have reported that the ubiquitin tent difference in the serum insulin level when serum
mRNA level in muscle of patients with catabolic condi- HCO3 increased, suggesting that the improvement in
tions such as head injury, sepsis, trauma, and gastric serum HCO3 did not change insulin sensitivity drasti-
cancer is high [34–37]. In some of these studies, there cally. Since we did not measure insulin sensitivity, this
was evidence for increased protein degradation plus an possibility cannot be excluded. Finally, it has been sug-
increase in mRNAs encoding subunits of the proteasome gested that uremia activates inflammatory responses that
or components of other proteolytic pathways. As far as decrease serum albumin and may stimulate protein loss
we know, however, the present study is the first to pro- [3, 8]. In fact, cytokine levels are high in blood from
vide evidence that changes in ubiquitin mRNA can be kidney failure patients and experimentally, TNF- injec-
therapeutically regulated in a condition associated with tion into rats is associated with muscle protein and
loss of muscle mass. Specifically, we found that the ubi- BCAA catabolism [45–49]. Based on available data, we
quitin mRNA level in individual patients with renal fail- cannot attribute a cause–effect relationship between the
ure falls when their serum HCO3 increased. decrease in serum TNF- and the improvement in serum
The signal(s) leading to higher levels of ubiquitin HCO3 and weight gain. The interconnections among cy-
mRNA in muscle (and by inference, ubiquitin-protea- tokine levels and transcriptional and functional respon-
some system proteolysis) was not identified in those re- ses in muscle are complex [50, 51]. It would be interesting
ports of clinical conditions associated with increased ubi- to learn if metabolic acidosis stimulates the release of
quitin mRNA in muscle, but in the patients with head or interacts with inflammatory cytokines as suggested in
injury, there was an increase in the plasma cortisol level studies of cultured cells [52].
[34]. This is relevant because we found that acidosis alone In summary, our results indicate that increasing the
does not increase activity of the ubiquitin-proteasome serum bicarbonate level in CAPD patients leads to a
system in muscle of rats unless there is a high physiologi- down-regulation of proteolysis via the ubiquitin-protea-
cal level of glucocorticoids; however, when both are pres- some pathway in muscle. There also is an increase in
ent, protein breakdown is activated and the ubiquitin plasma BCAA consistent with a decrease in their degra-
mRNA level rises in muscle [21, 29, 38]. A similar “per- dation. The number of patients studied was small, but
missive association” between glucocorticoids and muscle the agreement between our results and those in animals
proteolysis has been found in rat models of starvation provide compelling evidence that muscle wasting in dial-
and sepsis [39, 40]. Finally, Garibotto et al reported that ysis patients occurs via stimulation of these catabolic
the serum cortisol level in a group of acidotic, CRF pathways. It follows that protein malnutrition can be
patients was directly related to the rates of forearm mus- improved by correcting the acid-base status.
cle protein breakdown. In their study, serum cortisol
levels were within the normal range [30]. This suggests ACKNOWLEDGMENTS
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